CCR5 and HIV-1 infection: It is possible that these cells may be best preserved by early intervention with ART, including CCR5 blocking antiretroviral therapy, such as Maraviroc, commenced during primary HIV-1 infection, although a lack of reconstitution may necessitate intervention, for example with exogenous IL-7, or revaccination.